Genetic and molecular biological analysis of protein-protein interactions in coronavirus assembly

Advances in Experimental Medicine and Biology

Volumn 581, Issue , 2006, Pages 163-173

  Masters, Paul S ^a   Kuo, Lili ^a   Ye, Rong ^a   Hurst, Kelley R ^a   Koetzner, Cheri A ^a   Hsue, Bilan ^b  

^a NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^b Stratagene   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934435049     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-33012-9_29     Document Type: Conference Paper

References (54)

1. P. J. M. Rottier, in: The Coronaviridae, edited by S. G. Siddell (Plenum Press, New York, 1995), pp. 115-139.
2. J. Armstrong, H. Niemann, S. Smeekens, P. Rottier, and G. Warren, Sequence and topology of a model intracellular membrane protein, E1 glycoprotein, from a coronavirus, Nature 308, 751-752 (1984).
3. P. Rottier, D. Brandenburg, J. Armstrong, B. van der Zeijst, and G. Warren, Assembly in vitro of a spanning membrane protein of the endoplasmic reticulum: the E1 glycoprotein of coronavirus mouse hepatitis virus A59, Proc. Natl. Acad. Sci. USA 81, 1421-1425 (1984).
4. P. J. M. Rottier, G. W. Welling, S. Welling-Wester, H. G. M. Niesters, J. A. Lenstra, and B. A. M. Van der Zeijst, Predicted membrane topology of the coronavirus protein E1, Biochemistry 25, 1335-1339 (1986).
5. C. Risco, I. M. Anton, C. Sune, A. M. Pedregosa, J. M. Martin-Alonso, F. Parra, J. L. Carrascosa, and L. Enjuanes, Membrane protein molecules of transmissible gastroenteritis coronavirus also expose the carboxy-terminal region on the external surface of the virion, J. Virol. 69, 5269-5277 (1995).
6. K. V. Holmes, E. W. Dollar, and L. S. Sturman, Tunicamycin resistant glycosylation of a coronavirus glycoprotein: demonstration of a novel type of viral glycoprotein, Virology 115, 334-344 (1981).
7. P. J. M. Rottier, M. C. Horzinek, and B. A. M. van der Zeijst, Viral protein synthesis in mouse hepatitis virus strain A59-infected cells: effects of tunicamycin, J. Virol. 40, 350-357 (1981).
8. C. S. Ricard, C. A. Koetzner, L. S. Sturman, and P. S. Masters, A conditional-lethal murine coronavirus mutant that fails to incorporate the spike glycoprotein into assembled virions, Virus Research 39, 261-276 (1995).
9. D.-J. E. Opstelten, M. J. B. Raamsman, K. Wolfs, M. C. Horzinek, and P. J. M. Rottier, Envelope glycoprotein interactions in coronavirus assembly, J. Cell Biol. 131, 339-349 (1995).
10. V.-P. Nguyen and B. Hogue, Protein interactions during coronavirus assembly, J. Virol. 71, 9278-9284 (1997).
11. J. Tooze, S. A. Tooze, and G. Warren, Replication of coronavirus MHV-A59 in Sac- cells: determination of the first site of budding of progeny virions, Eur. J. Cell Biol. 33, 281-293 (1984).
12. P. J. M. Rottier and J. K. Rose, Coronavirus E1 protein expressed from cloned cDNA localizes in the Golgi region, J. Virol. 61, 2042-2045 (1987).
13. C. E. Machamer and J. K. Rose, A specific transmembrane domain of a coronavirus E1 glycoprotein is required for its retention in the Golgi region, J. Cell Biol. 105, 1205-1214 (1987).
14. C. E. Machamer, S. A. Mentone, J. K. Rose, and M. G. Farquhar, The E1 glycoprotein of an avian coronavirus is targeted to the cis Golgi complex, Proc. Natl. Acad. Sci. USA 87, 6944-6948 (1990).
15. J. Klumperman, J. Krijnse Locker, A. Meijer, M. C. Horzinek, H. J. Geuze, and P. J. M. Rottier, Coronavirus M proteins accumulate in the Golgi complex beyond the site of virion budding, J. Virol. 68, 6523-6534 (1994).
16. H. Vennema, G.-J. Godeke, J. W. A. Rossen, W. F. Voorhout, M. C. Horzinek, D.-J. E. Opstelten, and P. J. M. Rottier, Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes, EMBO J. 15, 2020-2028 (1996).
17. E. C. W. Bos, W. Luytjes, H. van der Meulen, H. K. Koerten, and W. J. M. Spaan, The production of recombinant infectious DI-particles of a murine coronavirus in the absence of helper virus, Virology 218, 52-60 (1996).
18. P. Baudoux, C. Carrat, L. Besnardeau, B. Charley, and H. Laude, Coronavirus pseudoparticles formed with recombinant M and E proteins induce alpha interferon synthesis by leukocytes, J. Virol. 72, 8636-8643 (1998).
19. E. Mortola and P. Roy, Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system, FEBS Lett. 576, 174-178 (2004).
20. E. Corse and C. E. Machamer, Infectious bronchitis virus E protein is targeted to the Golgi complex and directs release of virus-like particles, J. Virol. 74, 4319-4326 (2000).
21. E. Corse and C. E. Machamer, The cytoplasmic tails of infectious bronchitis virus E and M proteins mediate their interaction, Virology 312, 25-34 (2003).
22. Y. Huang, Z. Y. Yang, W. P. Kong, and G. J. Nabel, Generation of synthetic severe acute respiratory syndrome coronavirus pseudoparticles: implications for assembly and vaccine production, J. Virol. 78, 12557-12565 (2004).
23. C. A. M. de Haan, H. Vennema, and P. J. M. Rottier, Assembly of the coronavirus envelope: homotypic interactions between the M proteins, J. Virol. 74, 4967-4978 (2000).
24. G.-J. Godeke, C. A. de Haan, J. W. Rossen, H. Vennema, and P. J. M. Rottier, Assembly of spikes into coronavirus particles is mediated by the carboxy-terminal domain of the spike protein, J. Virol. 74, 1566-1571 (2000).
25. L. Kuo, G.-J. Godeke, M. J. B. Raamsman, P. S. Masters, and P. J. M. Rottier, Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier, J. Virol. 74, 1393-1406 (2000).
26. P. S. Masters and P. J. M. Rottier, Coronavirus reverse genetics by targeted RNA recombination, Curr. Topics Microbiol. Immunol. 287, 133-159 (2005).
27. L. Kuo and P. S. Masters, Genetic evidence for a structural interaction between the carboxy termini of the membrane and nucleocapsid proteins of mouse hepatitis virus, J. Virol. 76, 4987-4999 (2002).
28. S. J. Goebel, B. Hsue, T. F. Dombrowski, and P. S. Masters, Characterization of the RNA components of a putative molecular switch in the 3' untranslated region of the murine coronavirus genome, J. Virol. 78, 669-682 (2004).
29. R. Ye, C. Montalto-Morrison, and P. S. Masters, Genetic analysis of determinants for spike glycoprotein assembly into murine coronavirus virions: distinct roles for charge-rich and cysteine-rich regions of the endodomain, J. Virol. 78, 9904-9917 (2004).
30. E. C. W. Bos, W. Luytjes, and W. J. M. Spaan, The function of the spike protein of mouse hepatitis virus strain A59 can be studied on virus-like particles: cleavage is not required for infectivity, J. Virol. 71, 9427-9433 (1997).
31. K. W. Chang, Y. W. Sheng, and J. L. Gombold, Coronavirus-induced membrane fusion requires the cysteine-rich domain in the spike protein, Virology 269, 212-224 (2000).
32. B. J. Bosch, C. A. M. de Haan, S. L. Smits, and P. J. M. Rottier, Spike protein assembly into the coronavirion: exploring the limits of its sequence requirements, Virology 334, 306-318 (2005).
33. M. M. Parker and P. S. Masters, Sequence comparison of the N genes of five strains of the coronavirus mouse hepatitis virus suggests a three domain structure for the nucleocapsid protein, Virology 179, 463-468 (1990).
34. P. S. Masters, Localization of an RNA-binding domain in the nucleocapsid protein of the coronavirus mouse hepatitis virus, Arch. Virol. 125, 141-160 (1992).
35. G. W. Nelson and S. A. Stohlman, Localization of the RNA-binding domain of mouse hepatitis virus nucleocapsid protein, J. Gen. Virol. 74, 1975-1979 (1993).
36. K. R. Hurst, L. Kuo, C. A. Koetzner, R. Ye, B. Hsue, and P. S. Masters, A major determinant for membrane protein interaction localizes to the carboxy-terminal domain of the mouse coronavirus nucleocapsid protein, J. Virol. 79, in press (2005).
37. D. Escors, J. Ortego, H. Laude, and L. Enjuanes, The membrane M protein carboxy terminus binds to transmissible gastroenteritis coronavirus core and contributes to core stability, J. Virol. 75, 1312-1324 (2001).
38. L. S. Sturman, K. V. Holmes, and J. Behnke, Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid, J. Virol. 33, 449-462 (1980).
39. R. S. Baric, G. W. Nelson, J. O. Fleming, R. J. Deans, J. G. Keck, N. Casteel, and S. A. Stohlman, Interactions between coronavirus nucleocapsid protein and viral RNAs: implications for viral transcription, J. Virol. 62, 4280-4287 (1988).
40. R. Cologna, J. F. Spagnolo, and B. G. Hogue, Identification of nucleocapsid binding sites within coronavirus-defective genomes, Virology 277, 235-249 (2000).
41. K. Narayanan, A. Maeda, J. Maeda, and S. Makino, Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells, J. Virol. 74, 8127-8134 (2000).
42. K. Narayanan and S. Makino, Cooperation of an RNA packaging signal and a viral envelope protein in coronavirus RNA packaging, J. Virol. 75, 9059-9067 (2001).
43. K. Narayanan, C. J. Chen, J. Maeda, and S. Makino, Nucleocapsid- independent specific viral RNA packaging via viral envelope protein and viral RNA signal, J. Virol. 77, 2922-2927 (2003).
44. M. J. B. Raamsman, J. Krijnse Locker, A. de Hooge, A. A. F. de Vries, G. Griffiths, H. Vennema, and P. J. M. Rottier, Characterization of the coronavirus mouse hepatitis virus strain A59 small membrane protein E, J. Virol. 74, 2333-2342 (2000).
45. E. Corse and C. E. Machamer, The cytoplasmic tail of infectious bronchitis virus E protein directs Golgi targeting, J. Virol. 76, 1273-1284 (2002).
46. J. Torres, J. Wang, K. Parthasarathy, and D. X. Liu, The transmembrane oligomers of coronavirus protein E, Biophys. J. 88, 1283-1290 (2005).
47. J. Maeda, J. F. Repass, A. Maeda, and S. Makino, Membrane topology of coronavirus E protein, Virology 281, 163-169 (2001).
48. E. Arbely, Z. Khattari, G. Brotons, M. Akkawi, T. Salditt, and I. T. Arkin, A highly unusual palindromic transmembrane helical hairpin formed by SARS coronavirus E protein, J. Mol. Biol. 341, 769-779 (2004).
49. F. Fischer, C. F. Stegen, P. S. Masters, and W. A. Samsonoff, Analysis of constructed E gene mutants of mouse hepatitis virus confirms a pivotal role for E protein in coronavirus assembly, J. Virol. 72, 7885-7894 (1998).
50. L. Kuo and P. S. Masters, The small envelope protein E is not essential for murine coronavirus replication, J. Virol. 77, 4597-4608 (2003).
51. J. Ortego, D. Escors, H. Laude, and L. Enjuanes, Generation of a replication-competent, propagationdeficient virus vector based on the transmissible gastroenteritis coronavirus genome, J. Virol. 76, 11518-11529 (2002).
52. K. M. Curtis, B. Yount, and R. S. Baric, Heterologous gene expression from transmissible gastroenteritis virus replicon particles, J. Virol. 76, 1422-1434 (2002).
53. J. Maeda, A. Maeda, and S. Makino, Release of E protein in membrane vesicles from virus-infected cells and E protein-expressing cells, Virology 263, 265-272 (1999).
54. L. Wilson, C. McKinlay, P. Gage, and G. Ewart, SARS coronavirus E protein forms cation-selective ion channels, Virology 330, 322-331 (2004).